Pharmaceutical Medicine

Acknowledgement to Referees

• ACKNOWLEDGEMENT TO REFEREES

Clearing the Mist: The Distinct Roles of Transparency and Explainability for Using AI in Drug and Device Development

• Commentary

Timothé Ménard, Katrina A. Bramstedt

The Evolution of Medical Affairs Central Teams: Shaping Strategic Action and Driving Healthcare Transformation Through Scientific Interaction

• Open Access
• Leading Article

Manuel Leal Beckouche, Gustavo Resler Plat, Jorge A. Marinich, Carmen Moreno, Marta Moreno, Joana Gostkorzewicz, Inmaculada Iglesias, Ana Pérez Domínguez

Joint Clinical Assessments in Europe: Implications for Market Access, Reimbursement, and National HTA Alignment

• Review Article

Amit Dang, Sameera Tak

Studies of Cannabinoid-Based Products in ClinicalTrials.gov: A Scoping Review

• Open Access
• Systematic Review

Margaret Haney, Ziva D. Cooper, Hannah VanLaanen, Chandni Hindocha, Jennifer L. Triemstra

Considerations for Biosimilar Adoption in Pediatrics: A Scoping Review

• Systematic Review

Elaine Lau, Alicia Koo, Han Byul Kang, Meredith Ames, Cheyenne Matinnia, Avram Denburg

Development of a Competency Framework for Medical Affairs Professionals in Australasia

• Open Access
• Original Research Article

Andrew Weekes, Matthew Britland, Cathey Saha, Simon McErlane, Niloufar Ansari, Daniel Thurley, Victoria Elegant, Orin Chisholm

Evaluating the MAPA Medical Affairs Competency Framework: Insights from Amgen-Led Pilot Study in Australia, Japan and China

• Original Research Article

Riaz Abbas, Orin Chisholm, Victoria Elegant, Seigo Susa, Samantha Richards, Cae Tolman

Evaluating the Readability of Clinical Trial Content for Patients on Pharmaceutical Company Websites

• Original Research Article

Christopher Felix Brewer